Fosun Pharma (02196) Proposes Shareholder Approval for Up to RMB 100 Million Loan to Fosun Kite in Proportion to Equity Stake

Fosun Pharmaceutical(02196) announced that, in order to meet the operational plans and funding requirements of Fosun Kite Biotechnology Co., Ltd. (Fosun Kite), it intends to request the approval of the company's shareholders meeting for Shanghai Fosun Pharmaceutical Development Co., Ltd. (Fosun Pharmaceutical Industry), a controlled subsidiary, and KP EU C.V. (Kite Pharma), the other shareholder of Fosun Kite, to provide additional loans to Fosun Kite based on their respective equity stakes, with a total amount not exceeding RMB 200 million (inclusive). The loan may be provided directly or through entrusted loans, etc. Among this, Fosun Pharmaceutical Industry plans to provide a loan not exceeding RMB 100 million (inclusive) according to its 50% equity stake in Fosun Kite. The loan term will not exceed two years.